BlackRock's Li: Longer-Term Forecasting ‘Basically Pointless' on Uncertainty
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
28 minutes ago
- Yahoo
Should You Think About Buying LION E-Mobility AG (ETR:LMIA) Now?
LION E-Mobility AG (ETR:LMIA), is not the largest company out there, but it led the XTRA gainers with a relatively large price hike in the past couple of weeks. While good news for shareholders, the company has traded much higher in the past year. Less-covered, small caps tend to present more of an opportunity for mispricing due to the lack of information available to the public, which can be a good thing. So, could the stock still be trading at a low price relative to its actual value? Let's take a look at LION E-Mobility's outlook and value based on the most recent financial data to see if the opportunity still exists. We've found 21 US stocks that are forecast to pay a dividend yield of over 6% next year. See the full list for free. What's The Opportunity In LION E-Mobility? Good news, investors! LION E-Mobility is still a bargain right now. According to our valuation, the intrinsic value for the stock is €2.18, but it is currently trading at €1.41 on the share market, meaning that there is still an opportunity to buy now. However, given that LION E-Mobility's share is fairly volatile (i.e. its price movements are magnified relative to the rest of the market) this could mean the price can sink lower, giving us another chance to buy in the future. This is based on its high beta, which is a good indicator for share price volatility. See our latest analysis for LION E-Mobility What kind of growth will LION E-Mobility generate? Future outlook is an important aspect when you're looking at buying a stock, especially if you are an investor looking for growth in your portfolio. Buying a great company with a robust outlook at a cheap price is always a good investment, so let's also take a look at the company's future expectations. LION E-Mobility's earnings over the next few years are expected to increase by 100%, indicating a highly optimistic future ahead. This should lead to more robust cash flows, feeding into a higher share value. What This Means For You Are you a shareholder? Since LMIA is currently undervalued, it may be a great time to accumulate more of your holdings in the stock. With a positive outlook on the horizon, it seems like this growth has not yet been fully factored into the share price. However, there are also other factors such as capital structure to consider, which could explain the current undervaluation. Are you a potential investor? If you've been keeping an eye on LMIA for a while, now might be the time to enter the stock. Its prosperous future outlook isn't fully reflected in the current share price yet, which means it's not too late to buy LMIA. But before you make any investment decisions, consider other factors such as the strength of its balance sheet, in order to make a well-informed investment decision. If you want to dive deeper into LION E-Mobility, you'd also look into what risks it is currently facing. To that end, you should learn about the 4 warning signs we've spotted with LION E-Mobility (including 1 which is significant). If you are no longer interested in LION E-Mobility, you can use our free platform to see our list of over 50 other stocks with a high growth potential. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Yahoo
28 minutes ago
- Yahoo
Is CRISPR Therapeutics' (CRSP) Rising Net Loss a Sign of Bold Investment or Growing Pressure?
CRISPR Therapeutics AG recently reported its second quarter 2025 earnings, posting revenue of US$892,000, up from US$517,000 a year ago, but recording a net loss of US$208.55 million, up from US$126.41 million in the same period last year. Despite modest revenue gains, the significantly wider loss per share suggests rising costs or investment pressures are impacting the company's financial trajectory. We'll explore how the widening net loss and higher reported expenses could reshape CRISPR Therapeutics' investment narrative going forward. The end of cancer? These 26 emerging AI stocks are developing tech that will allow early identification of life changing diseases like cancer and Alzheimer's. What Is CRISPR Therapeutics' Investment Narrative? To be a shareholder in CRISPR Therapeutics, you need conviction in the promise of gene-editing breakthroughs and the company's ability to translate pipeline progress into eventual commercial returns. The latest earnings report, though, spotlights a widening net loss and sharply higher operating expenses. While ongoing clinical trials and recent index inclusions remain key near-term catalysts, the size of the reported quarterly loss raises questions around cash burn and the timeline to profitability. This new financial data could shift expectations for the pace of hiring, R&D investment, or the need for additional funding, potentially affecting sentiment around CRISPR's risk profile. On balance, the recent news does not appear to instantly derail the main product development catalysts investors were tracking, but it sharpens focus on the sustainability of current spending levels and paths to revenue growth in a high-cost environment. But with losses widening, funding needs are something every investor should watch closely. CRISPR Therapeutics' shares have been on the rise but are still potentially undervalued. Find out how large the opportunity might be. Exploring Other Perspectives Eighteen members of the Simply Wall St Community offer fair value estimates for CRISPR Therapeutics, ranging from US$14.57 to US$150.97 per share. As these forecasts reveal, opinions differ widely on the company's trajectory, particularly given growing expenses flagged in the latest earnings. Exploring several alternative viewpoints can help you understand the breadth of market expectations. Explore 18 other fair value estimates on CRISPR Therapeutics - why the stock might be worth less than half the current price! Build Your Own CRISPR Therapeutics Narrative Disagree with this assessment? Create your own narrative in under 3 minutes - extraordinary investment returns rarely come from following the herd. A great starting point for your CRISPR Therapeutics research is our analysis highlighting 2 key rewards and 1 important warning sign that could impact your investment decision. Our free CRISPR Therapeutics research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate CRISPR Therapeutics' overall financial health at a glance. Ready For A Different Approach? Don't miss your shot at the next 10-bagger. Our latest stock picks just dropped: Find companies with promising cash flow potential yet trading below their fair value. Trump has pledged to "unleash" American oil and gas and these 22 US stocks have developments that are poised to benefit. These 14 companies survived and thrived after COVID and have the right ingredients to survive Trump's tariffs. Discover why before your portfolio feels the trade war pinch. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include CRSP. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Fast Company
30 minutes ago
- Fast Company
How nonprofits should (and shouldn't) be using tech
Businesses have long leaned on cutting-edge technology to maximize profits, while the nonprofit sector has traditionally been slower to incorporate innovations such as AI. But if we want to tackle the world's most pressing social problems, that must change, says philanthropist and MacArthur Genius grant recipient Jim Fruchterman in a new book. In Technology for Good: How Nonprofit Leaders Are Using Software and Data to Solve Our Most Pressing Social Problems, out September 2nd, Fruchterman highlights social good organizations that are using technology to solve real-world problems—homelessness, mental illness, climate change, child abuse, and more. Fruchterman is a tech-for-good leader and the founder of the nonprofit Benetech, which created Bookshare, an online library for people who are blind or visually impaired. He spoke with Fast Company about some of the ways technology is being used to make the world a better place and what he hopes readers glean from his book. It's refreshing to talk to a business leader about how to use technology for social good instead of how to use it to drive profits. [Laughs.] I call it moving from money to meaning. What are the challenges that nonprofits and social-good organizations face when it comes to technology? One is a lack of money. Funding is tight. And while tech is often cost-effective, if you have a hard time coming up with the money to buy the tech, it's hard to use. There are also often low levels of tech capacity among the staff. People are used to using the telephone as opposed to going on a Zoom call. The social sector also prioritizes different things than the for-profit sector. It's not just about efficiency. People are still pretty important in the social change sector. Saying, 'Hey, you can get rid of a bunch of people' (by implementing a new technology) may not be the best sales pitch for a charity that is trying to help people. What are some social problems that technology could help solve? I spotlight in my book TalkingPoints, which helps teachers communicate with kids' parents who don't speak English. If you can get the parents more engaged, kids are a lot more successful in school. That's a great example of a technology that fills a need for immigrant parents. Community Solutions' Built for Zero initiative is trying to end homelessness. For years, we treated the symptoms: Let's build temporary housing, get people food and clothing. They're asking, 'Can we say that everyone who was homeless three months ago is now housed?' The key tech innovation is a by-name list keeping track of everyone across community places that these people go into. When shelters say, 'Our beds have been 80% used this month,' that measures output, but it doesn't say anything about whether we're solving the homelessness problem. So much of what the social sector does is move information around—well, that's what information technology is for. What would you say to a nonprofit leader who feels overwhelmed by or unqualified to make decisions around technology? Find people in your field who are ahead of you on the technology journey and learn from them. Talk to your peers. If they're saying, 'We're writing a third more grants with the same amount of staff' using ChatGPT or Claude, then that's worth paying attention to, because it's not their business to sell you things. In your book, you highlight some bad ideas in tech-for-good efforts. Which do you see repeated the most? The cult of the custom. It's the idea that 'my nonprofit is such a unique snowflake that I need custom software built to solve my organization's problem.' And businesses stopped writing custom software 20 years ago because no golf course, no restaurant, no dentist needs to be writing software to run their company. When you write your own software, you're the only customer. It means that every bug that needs to be fixed, you're the only one paying for it. You should look for a product that can be adapted to your needs. Also: I see lots of people building an app that no one will download. Or people following whatever the latest fad is—five or eight years ago, that was blockchain. That didn't work out. Three to five years ago, it was the metaverse. That didn't work out. Right now, it's generative AI. I'm glad you brought up AI. What's your take on where AI should and shouldn't be used in social impact work? I think you shouldn't replace human empathy and understanding with AI that doesn't understand what it's saying and have any empathy whatsoever. People in the nonprofit sector turn to human beings to help them. The best applications of AI in social good are around making the people on the frontlines of social change more effective. Let's say I'm trying to automate a mental health counselor. Do I want to replace the counselor with a chatbot? Right now, it's not a great idea. But if we can instead cut their amount of data entry time or paperwork time in half, then that's time they can spend with another person who needs their help.
